{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:45:37Z","timestamp":1759099537130},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cjca.2013.03.023","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T03:52:15Z","timestamp":1371786735000},"page":"S14-S23","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S","title":["Silent Atrial Fibrillation as a Stroke Risk Factor and Anticoagulation Indication"],"prefix":"10.1016","volume":"29","author":[{"given":"Taya V.","family":"Glotzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.03.023_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8167.2006.00609.x","article-title":"Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial","volume":"17","author":"Patten","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation. Relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.03.023_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1540-8159.2009.02181.x","article-title":"Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables","volume":"32","author":"Quirino","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2003.08.027","article-title":"Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. Implications for optimal patient care","volume":"43","author":"Israel","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.03.023_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.hrthm.2004.10.042","article-title":"Relationship between atrial tachyarrhythmias and symptoms","volume":"2","author":"Strickberger","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2013.03.023_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jacc.2004.11.050","article-title":"Role of transtelephonic electro- cardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation","volume":"45","author":"Senatore","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1540-8159.2007.00693.x","article-title":"Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation","volume":"30","author":"Arya","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib9","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1161\/CIRCULATIONAHA.108.838474","article-title":"Twenty-four-hour Holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy. Up to 12 months experience with a novel permanently implantable heart rhythm monitor device","volume":"120","author":"Hanke","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.03.023_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1540-8167.2010.01923.x","article-title":"Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring","volume":"22","author":"Pokushalov","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2013.03.023_bib12","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1009823001707","article-title":"Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management","volume":"4","author":"Savelieva","year":"2000","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Sub-Study of MOST","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.03.023_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cjca.2012.08.019","article-title":"Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation","volume":"29","author":"Healey","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM200005113421902","article-title":"Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators","volume":"342","author":"Connolly","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.03.023_bib17","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1056\/NEJMoa013040","article-title":"Ventricular pacing or dual-chamber pacing for sinus-node dysfunction","volume":"346","author":"Lamas","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.03.023_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2013.03.023_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1540-8159.2007.00682.x","article-title":"Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial","volume":"30","author":"Orlov","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib21","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-006-7622-y","article-title":"Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: TRENDS","volume":"15","author":"Glotzer","year":"2006","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib23","first-page":"2118","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: executive summary","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.03.023_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS Study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib25","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2013.03.023_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2013.03.023_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib28","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring","volume":"42","author":"Boriani","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2013.03.023_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/europace\/eur293","article-title":"Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population","volume":"14","author":"Shanmugam","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2013.03.023_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.03.023_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2006.02.016","article-title":"ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)","volume":"152","author":"Hohnloser","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2013.03.023_bib32","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2013.03.023_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2012.06.034","article-title":"Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention","volume":"110","author":"Ziegler","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a prior history of thromboembolic events","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2013.03.023_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ahj.2009.07.002","article-title":"Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort. The IMPACT study","volume":"158","author":"Ip","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2013.03.023_bib36","unstructured":"Incidence of AF in high risk patients (REVEAL AF). Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01727297. Accessed February 18, 2013."},{"key":"10.1016\/j.cjca.2013.03.023_bib37","unstructured":"Prevalence of sub-clinical atrial fibrillation using an implantable cardiac monitor (ASSERT-II). Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01694394. Accessed February 18, 2013."},{"key":"10.1016\/j.cjca.2013.03.023_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1109\/TBME.2007.903707","article-title":"A\u00a0detector for a chronic implantable atrial tachyarrhythmia monitor","volume":"55","author":"Sarkar","year":"2008","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.cjca.2013.03.023_bib39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1540-8159.2004.00569.x","article-title":"Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies","volume":"27","author":"Purerfellner","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2013.03.023_bib40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2013.03.023_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2013.03.023_bib42","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2013.03.023_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCOUTCOMES.111.964205","article-title":"Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project","volume":"5","author":"Boriani","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13002079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13002079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T04:20:36Z","timestamp":1539577236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13002079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0828282X13002079"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.03.023","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}